AVANOS MEDICAL, INC. (AVNS)

13.95 0 (0%)

As of 2026-04-02 15:10:05 EST

Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.

Traded asNYSE: AVNS
ISINUS05350V1061
CIK0001606498
LEI549300YCXWOM7NEWMQ58
EIN464987888
SectorHealthcare
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
CEOJoseph F. Woody
Employees5,380
Fiscal Year End1231
Address5405 WINDWARD PARKWAY, ALPHARETTA, GA, 30004
Phone844-428-2667
Websitehttps://avanos.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
AVNSAVANOS MEDICAL, INC.2026-04-02 15:10:0513.9500
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
AVNS0001606498AVANOS MEDICAL, INC.US05350V1061549300YCXWOM7NEWMQ58464987888NYSE3842Orthopedic, Prosthetic & Surgical Appliances & Supplies1231DE5405 WINDWARD PARKWAYALPHARETTAGA30004UNITED STATESUS844-428-26675405 WINDWARD PARKWAY, ALPHARETTA, GA, 300045405 WINDWARD PARKWAY, ALPHARETTA, GA, 30004Halyard Health, Inc.Healthcare2014Joseph F. Woody5,380https://avanos.com/565,451,13346,614,94746,503,458Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.2026-04-02 17:43:43
This is a preview of the latest data. Subscribe to access the full data.
AVNS Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
AVNS Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025565,451,133-341,822,338-37.675846,503,458500,3081.0876
2024907,273,471-284,441,490-23.868246,003,150-199,842-0.4325
20231,191,714,961-87,419,747-6.834346,202,992-395,903-0.8496
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Sigfrido DelgadoSenior Vice President2025471,9750668,750393,39132,4531,722,819
Jason M. PickettChief Financial Officer2025515,0000450,000321,90034,2181,321,118
Scott M. GalovanChief Financial Officer2025392,85701,100,000332,90463,3782,039,138
David C. PacittiChief Executive Officer2025751,705500,0007,000,0001,148,66769,4329,469,803
Michael C. GreinerChief Executive Officer2025550,41601,575,000493,2512,139,4415,283,109
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20194,700
20184,700
201713,000
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue701,200,000687,800,000673,300,000
Cost Of Revenue347,300,000306,500,000293,600,000
Gross Profit353,900,000381,300,000379,700,000
Research And Development Expenses23,300,00026,200,00027,200,000
General And Administrative Expenses315,600,000318,500,000335,000,000
Operating Expenses———
Operating Income-61,600,000-396,200,0004,200,000
Net Income-72,900,000-392,100,000-61,800,000
Earnings Per Share Basic-1.57-8.53-1.32
Earnings Per Share Diluted-1.57-8.53-1.32
Weighted Average Shares Outstanding Basic46,300,00046,000,00046,600,000
Weighted Average Shares Outstanding Diluted46,300,00046,000,00046,600,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents89,800,000107,700,00087,700,000
Marketable Securities Current———
Accounts Receivable103,800,000132,800,000142,800,000
Inventories148,000,000138,800,000163,200,000
Non Trade Receivables100,0004,900,00014,100,000
Other Assets Current———
Total Assets Current355,400,000393,400,000487,000,000
Marketable Securities Non Current———
Property Plant And Equipment113,400,000110,700,000117,200,000
Other Assets Non Current31,500,00023,200,00019,300,000
Total Assets Non Current718,300,000760,800,0001,205,400,000
Total Assets1,073,700,0001,154,200,0001,692,400,000
Accounts Payable55,500,00054,300,00056,300,000
Deferred Revenue———
Short Term Debt10,200,0009,400,0008,600,000
Other Liabilities Current91,300,00091,300,00093,200,000
Total Liabilities Current165,200,000165,900,000234,600,000
Long Term Debt90,300,000125,300,000159,400,000
Other Liabilities Non Current13,500,0004,400,00010,000,000
Total Liabilities Non Current130,300,000159,800,000221,500,000
Total Liabilities295,500,000325,700,000456,100,000
Common Stock500,000500,000500,000
Retained Earnings-779,900,000-707,000,000-314,900,000
Accumulated Other Comprehensive Income-32,000,000-44,600,000-27,000,000
Total Shareholders Equity778,200,000828,500,0001,236,300,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization38,900,00045,500,00046,100,000
Share Based Compensation Expense12,600,00013,800,00015,800,000
Other Non Cash Income Expense-9,300,000-1,200,000—
Change In Accounts Receivable-30,900,0006,600,000-39,000,000
Change In Inventories-200,000-39,000,000-4,700,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable600,000-900,000-14,400,000
Change In Other Liabilities-12,900,000-11,400,000-27,700,000
Cash From Operating Activities74,700,000100,700,00032,400,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment31,600,00017,800,00017,800,000
Acquisition Of Business28,000,000049,600,000
Other Investing Activities———
Cash From Investing Activities-60,600,000-27,500,00021,600,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock3,300,00012,800,00019,100,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt25,000,00045,000,000115,000,000
Other Financing Activities———
Cash From Financing Activities-37,000,000-49,100,000-94,200,000
Change In Cash-17,900,00020,000,000-40,000,000
Cash At End Of Period89,800,000107,700,00087,700,000
Income Taxes Paid14,100,000——
Interest Paid6,500,00011,500,00014,700,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-1.57-8.53-1.32
Price To Earnings Ratio-7.1529-1.8664-16.9924
Earnings Growth Rate-81.5944546.2121-222.2222
Price Earnings To Growth Ratio0.0877-0.00340.0765
Book Value Per Share16.807818.010926.53
Price To Book Ratio0.66810.88390.8455
Ebitda-12,100,000-334,400,000-700,000
Enterprise Value530,649,000759,320,0001,125,538,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.12910.16260.1359
Capital Expenditures41,600,00039,000,000-600,000
Free Cash Flow33,100,00061,700,00033,000,000
Return On Equity-0.0937-0.4733-0.05
One Year Beta0.76650.96771.1862
Three Year Beta0.90990.96760.9531
Five Year Beta0.90421.10991.1292
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Hurley John JosephPrincipal Accounting Officer2026-03-132,211A13,592
Galovan Scott MichaelSVP, Chief Financial Officer2026-03-1370,115A96,697
Pacitti DavidChief Executive Officer2026-03-13241,021A241,021
Delgado SigfridoSVP, Operations2026-03-1337,782A59,696
Pacitti DavidChief Executive Officer2026-03-13101,341A343,388
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Nicholas Van Taylor2020-04-13TX03Sale2020-03-17—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Bangor Savings Bank2026-03-314343114
GOLDMAN SACHS GROUP INC2025-12-315,069,098451,38911.23
Rockefeller Capital Management L.P.2025-12-314494011.225
PEAK6 LLC2025-12-31238,07621,20011.23
Corient Private Wealth LLC2025-12-31234,23220,85511.2315
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
E Trade Trust2026-01-31E*TRADE No Fee Total Market Index FundETTOX4495,980.680.009
J.P. Morgan Exchange-Traded Fund Trust2026-01-31JPMorgan Diversified Return U.S. Small Cap Equity ETFJPSE14,299190,462.680.0353
Tidal Trust III2026-01-31Intech S&P Small-Mid Cap Diversified Alpha ETFSMDX4,83064,335.60.0551
VICTORY PORTFOLIOS III2026-01-31Victory Extended Market Index FundUSMIX5,02966,986.280.0087
VICTORY PORTFOLIOS III2026-01-31Victory Small Cap Stock Fund Institutional SharesUISCX70,347937,022.040.1098
This is a preview of the latest data. Subscribe to access the full data.